Anti-Factor-Xa and Activated Partial Thromboplastin Time Concordance and Outcomes in Adults Undergoing Extracorporeal Membrane Oxygenation: A Secondary Analysis of the Pilot Low-Dose Heparin in Critically Ill Patients Undergoing Extracorporeal Membrane Oxygenation Randomized Trial

OBJECTIVES: To determine the concordance between activated partial thromboplastin time (aPTT) and anti-factor-Xa (anti-Xa) in adults undergoing extracorporeal membrane oxygenation (ECMO) and to identify the factors associated with discordant paired aPTT/anti-Xa. DESIGN: Pre-planned secondary analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Aubron, Cécile, Chapalain, Xavier, Bailey, Michael, Board, Jasmin, Buhr, Heidi, Cartwright, Bruce, Dennis, Mark, Hodgson, Carol, Forrest, Paul, McIlroy, David, Murphy, Deirdre, Murray, Lynne, Pellegrino, Vincent, Pilcher, David, Sheldrake, Jayne, Tran, Huyen, Vallance, Shirley, Cooper, D. James, McQuilten, Zoe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635598/
https://www.ncbi.nlm.nih.gov/pubmed/37954899
http://dx.doi.org/10.1097/CCE.0000000000000999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635598/
https://www.ncbi.nlm.nih.gov/pubmed/37954899
http://dx.doi.org/10.1097/CCE.0000000000000999

Ejemplares similares